/
ESLA
$1.03+$0.05 (+4.80%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$42.3M
43M shares
52-week range
$0.78 – $3.15
11% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Borrow rate
14.62%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-2.44
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — |
| R&D | $457.2K | $1.4M | $10.5M | $4.1M | $6.4M | $10.2M |
| Operating income | −$733.7K | −$1.7M | −$1.6M | −$7.3M | −$8.8M | −$13.1M |
| EBITDA | −$733.7K | −$11.2K | −$687.0K | −$7.3M | −$8.8M | −$13.1M |
| Net income | −$733.7K | −$1.7M | −$996.1K | −$7.3M | −$8.8M | −$13.1M |
| Net margin | — | — | — | — | — | — |
| EPS (diluted) | -0.02 | -0.29 | -0.17 | -0.21 | -0.25 | -0.35 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-0.39 | $-0.39–$-0.39 | 1 |
| 2027 | $0 | $-0.32 | $-0.32–$-0.32 | 1 |
| 2028 | $99M | $-0.23 | $-0.23–$-0.23 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.02
Price
$1.03
Implied downside
-98%
Peer comparison
Estrella Immunopharma, Inc. Common Stock
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
www.estrellabio.com- IPO / List date
- Oct 2, 2023
- HQ
- EMERYVILLE, CA
Held by traders on TradeandTell
No one on the platform currently holds ESLA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 62,795 | $66.6K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ESLA yet.
